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Background: Thoracic aortic stent grafts require proximal and distal landing zones of adequate length to effectively
exclude thoracic aortic lesions. The origins of the left subclavian artery and other aortic arch branch vessels often impose
limitations on the proximal landing zone, thereby disallowing endovascular repair of more proximal thoracic lesions.
Methods: Between October 2000 and November 2005, 112 patients received stent grafts to treat lesions involving the
thoracic aorta. The proximal aspect of the stent graft partially or totally occluded the origin of at least one great vessel in
28 patients (25%). The proximal attachment site was in zone 0 in one patient (3.6%), zone 1 in three patients (10.7%), and
zone 2 in 24 patients (85.7%). Patients with proximal implantation in zones 0 or 1 underwent debranching procedures
of the supra-aortic vessels before stent graft repair. In one patient who underwent zone 1 deployment, the left subclavian
artery was revascularized before stent graft deployment. Among patients who underwent zone 2 deployment with partial
or complete occlusion of the left subclavian artery, none underwent prior revascularization. Patients were assessed
postoperatively and at follow-up for development of neurologic symptoms as well as symptoms of left upper extremity
claudication or ischemia.
Results: Mean follow-up was 7.3 months. Among the 24 patients with zone 2 implantation, 10 (42%) had partial left
subclavian artery coverage at the time of their primary procedure. A total of 19 patients experienced complete cessation
of antegrade flow through the origin of the left subclavian artery without revascularization at the time of the initial
endograft repair as a result of a secondary procedure or as a consequence of left subclavian artery thrombosis. Left upper
extremity symptoms developed in three (15.8%) patients that did not warrant intervention, and rest pain developed in one
(5.3%), which was treated with the deployment of a left subclavian artery stent. Two primary (type IA and type III)
endoleaks (7.1%) and one secondary endoleak (type IA) (3.6%) were observed in patients who underwent zone 2
deployment. Three cerebrovascular accidents were observed. Thoracic aortic lesions were successfully excluded in all
patients who underwent supra-aortic debranching procedures.
Conclusion: Intentional coverage of the origin of the left subclavian artery to obtain an adequate proximal landing zone
during endovascular repair of thoracic aortic lesions is well tolerated and may be managed expectantly, with some
exceptions. ( J Vasc Surg 2007;45:90-5.)Thoracic endovascular aortic repair has become a viable
option for treating many aortic lesions that occur along this
vascular territory. Obtaining proximal and distal landing
zones of adequate length is necessary for the successful
exclusion of thoracic vascular lesions to protect against
rupture. Although the distal landing zone is often limited
by the origins of the mesenteric vessels, extra-anatomic
bypass has allowed extension of the distal landing zone into
the abdominal aortic territory for stent graft exclusion of
thoracoabdominal aneurysms.1 Likewise, within the terri-
tory of the aortic arch, the supra-aortic vessels impose
limitations on the length of the proximal landing zone.
Many thoracic aortic lesions are close to or involve the
left subclavian artery (SCA),2,3 requiring coverage of the
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90origin of this vessel by the endograft.4 Recent experience
has suggested that expectant management of left SCA
coverage is acceptable, with some exceptions.5-7 Over-
stenting of the left SCA, with or without revascularization,
extends the proximal landing zone and thereby allows
endograft exclusion of these more proximal thoracic aortic
lesions.
MATERIALS AND METHODS
Between October 2000 and November 2005, 112
patients received stent grafts to treat lesions of the thoracic
aorta. Patient names and medical record numbers were
obtained from the University of North Carolina Hospitals
Thoracic Endovascular Repair Database. Patient demo-
graphics, in-patient hospital information, clinic visits, and
radiologic data were obtained from electronic and paper
records. Institutional Review Board approval was obtained
for review of all patient records relevant to this review.
Of the 112 patients in our database, 28 (25%) were
identified who had endograft deployment proximal to the
distal aspect of the origin of the left SCA (zone 0, 1, or 2).
The proximal attachment site was in zone 0 in one patient
(3.6%), zone 1 in three patients (10.7%), and zone 2 in 24
patients (85.7%). A retrospective review was performed of
patients who had complete or partial coverage of the origin
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branching bypass procedures of the aortic arch vessels
before endograft deployment.
Preoperative evaluation involved computer tomogra-
phy (CT) angiography (CTA) of the chest, abdomen, and
pelvis with multiplanar reconstruction. When medically
indicated, as in situations of acute or chronic renal insuffi-
ciency, magnetic resonance angiography (MRA) was sub-
stituted for CTA evaluation. To further evaluate cerebro-
vascular anatomy, most of the patients in this subgroup
underwent preoperative carotid and vertebral artery duplex
ultrasonography, thoracic digital subtraction angiography,
or MRA, or a combination. In patients who did not un-
dergo supplemental preoperative imaging, the arch vessel
anatomy was evaluated intraoperatively before endograft
deployment.
Proximal landing zones were classified in relation to the
origins of the supra-aortic arch vessels as previously de-
scribed.8,9 The location of proximal deployment was de-
fined by the covered portion of the stent graft in cases
where the proximal component contained an uncovered or
bare section. Aortic debranching bypass procedures were
performed in patients who were to undergo zone 0 or zone
1 deployment. Three patients requiring zone 1 deployment
underwent revascularization of their left common carotid
artery (CCA) with a right-to-left carotid–carotid bypass
using a ringed 8-mm polytetrafluoroethylene (PTFE) graft.
One of these patients also received a left CCA–left SCA
bypass with a 6-mm ringed PTFE graft owing to stenosis of
his right vertebral artery and the risk of compromised
basilar blood flow with left SCA coverage.
For one patient who required zone 0 deployment to repair
a thoracic arch aneurysm, an ascending arch–innominate
artery and left CCA bypass was performed. Access was ob-
tained through a median sternotomy, and a 10-mm Dacron
bypass graft was anastomosed in an end-to-side fashion using
a side-biting clamp on the ascending arch, with the distal
anastomosis performed in an end-to-side fashion to the in-
nominate artery. The left CCA was transected and reim-
planted on the distal aspect of the bypass graft.
After hospital discharge and recovery from their bypass
procedure, patients returned for endograft exclusion of
their thoracic aortic lesions.
For endograft repair, anatomic criteria and graft
selection were defined by individual instructions for use.
Criteria generally included a proximal and distal landing
zone of 2 cm in length, and endografts were oversized
10% to 20% for elective cases. Commercially available
thoracic endograft devices were used when available and
are listed in Table I. Owing to a lack of commercially
available thoracic stent graft components early in our expe-
rience, handmade and abdominal aortic aneurysm (AAA)
endograft components were used in four patients.
Follow-up was performed at approximately 1 month, 6
months, 1 year, and annually thereafter. Mean follow-up
was 7.3 months. Radiologic evaluation during follow-up
consisted of cross-sectional and plain film imaging (four-
view radiographs of the chest). Patients were assessed forthe development of neurologic and left upper extremity
symptoms. Outcomes and endoleak classification were de-
fined as previously described.10
Primary technical, primary clinical, and assisted primary
clinical success was 100%, 89%, and 96%, respectively. Of
the 28 patients, 19 (68%) were treated electively and 9
(32%) were treated emergently. The etiology of electively
and emergently treated thoracic lesions is listed in Table I.
The average age of the patients was 63.2 years (range, 18 to
84); 19 (68%) were men and nine (32%) were women.
Nineteen patients (68%) had three or more chronic comor-
bidities as outlined in our previous report.11 Four patients
had undergone previous open AAA repair, and all under-
went cerebrospinal fluid drainage at the time of endograft
deployment. All patients were classified as having amAmer-
ican Society of Anesthesiologists (ASA) physical status of
3.
RESULTS
The overall 30-day mortality was 11% (3/28). The
30-day mortality for elective and emergent subgroups was
5% (1/19) and 22% (2/9), respectively (2 analysis; PNS).
Table I. Descending thoracic aorta etiology and
endografts utilized
Lesion n %
Total endovascular repairs in case series 28 100
Elective repairs 19 68
Degenerative/atherosclerotic aneurysms 10
Fusiform 8
Saccular 2
Pseudoaneurysms 9
Chronic dissection 4
Chronic transection* 3
Anastomotic 1
Penetrating Ulcer 1
Emergent repairs 9 32
Acute Stanford type B dissection 4
Traumatic (acute transection) 3
Infectious (mycotic) 1
Anastomotic w/fistula to bronchus 1
Endografts used 28 100
Talent Thoracic† 9 32
Gore TAG 8 29
Zenith TX2 TAA§ 4 14
AAA endograft components** 4 14
Bolton Relay†† 2 7
Hand-made‡‡ 1 4
AAA, Abdominal aortic aneurysm; TAA, thoracic aortic aneurysm.
‡W. L. Gore & Associates Inc, Flagstaff, Ariz.
*All 3 patients reported a history of blunt chest trauma.
†Medtronic AVE, Santa Rosa, Calif.
§Cook Inc, Bloomington, Ind.
**One patient received a modified main body Zenith AAA endovascular
graft (Cook Inc) and two main body extensions. Two patients received AAA
extender components of the Gore Excluder Bifurcated Endoprosthesis
(W. L Gore & Associates Inc).
††Bolton Medical, Sunrise, Fla.
‡‡Constructed from Gianturco Z-stents and woven Dacron graft.Both deaths in the emergently treated subgroup occurred n
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as a complication of insults sustained from acute type B
dissections. The electively treated patient who died had
undergone aortomesenteric bypass grafting the day before
thoracic endografting to extend his distal landing zone. He
died 6 days after endograft deployment from MSOF. Two
additional patients died during follow-up at approximately
5 and 18 months from complications of pre-existing end-
stage renal disease and congestive heart failure, respectively.
No deaths or complications were due to aneurysm rupture.
Common complications after elective and emergent
endograft repair are summarized in Table II. There were no
cases of paraplegia. No major complications developed in
the four patients who underwent debranching bypass pro-
cedures before endograft deployment in zones 0 or 1, and
none were found to have endoleaks during follow-up. One
patient who underwent a right-to-left CCA bypasses with-
out left SCA revascularization reported mild left hand
claudication and dizziness with rotation of his head to the
far right, which resolved with return tomidline. The patient
denied neurologic symptoms with increased activity of his
left upper extremity, and carotid and vertebral duplex ul-
trasound imaging demonstrated patency of the bypass
Table II. Complications
n %
Total endovascular repairs in case series 28 100
Elective repairs 19 68
30-day mortality 1 5
Complications
MSOF 1
Respiratory failure 1
Cardiac 0
Renal (ARF/ARI)b 0
Endoleaks 2
Emergent repairs 9 32
30-day Mortality 2 22
Complications
MSOFa 2
Respiratory failure 6
Cardiac 0
Renal (ARF/ARI)b 2
Endoleaks 1
Complete left SCA coverage* 18 64
Debranching procedure 4
Left subclavian artery revascularization 1
Cerebrovascular accident 2
Left upper extremity symptoms 3
Partial left SCA coverage* 10 36
Cerebrovascular accident 1
Left upper extremity symptoms 0
Conversion to total left SCA coverage/occlusion 2
Left SCA vessel thrombosis 1
Coverage following a secondary procedure 1
Left upper extremity symptoms 1
MSOF,multisystem organ failure;ARF, acute renal failure;ARI, acute renal
insufficiency; SCA, subclavian artery.
*Complete or partial coverage of the left subclavian artery at the time of
primary endograft deployment.graft, retrograde flow in the left vertebral artery, and nochange in flow patterns when the patient turned his head to
the right to reproduce his symptoms.
Of the 24 patients who underwent deployment in zone
2, 14 (58.3%) had complete coverage of the origin of the left
SCA at the time of primary endograft repair. None of these
patients underwent left SCA revascularization before en-
dograft repair. One primary endoleak was detected (type III),
which was successfully treated with the deployment of an
additional stent graft component. One patient who received a
thoracic endograft to treat a contained ruptured mycotic
aneurysm reported left upper extremity rest pain. A preproce-
dural thoracic arteriogramhad demonstrated a transverse arch
origin of the left vertebral artery. The patient underwent left
SCA stent placement, resulting in resolution of symptoms.
Of the 10 zone 2 patients (35.7%) who underwent
partial coverage of the origin of the left SCA, one patient
was found to have thrombosis of the proximal 2 cm of the
left SCA, with distal reconstitution on follow-up CT scan at
14 months, and remained asymptomatic. Two type IA
endoleaks were observed in two patients and occurred at 7
days and 6 months after endograft deployment, respec-
tively. One patient underwent endovascular balloon re-
modeling, resulting in total occlusion of the origin of the
left SCA and the development of numbness and tingling in
her left upper extremity with activity, but her symptoms
were not severe enough to warrant an intervention. The
second patient underwent deployment of an additional
stent graft component and attempted coil embolization;
however, these did not resolve the endoleak.
Three cerebrovascular accidents (CVAs) (10.7%) were
observed in our subgroup of 28 patients, an incidence that
appeared higher than the five (4.5%) that occurred in our
overall series of 112 patients. When the incidence of CVAs
in patients who underwent zone 0, 1, or 2 deployment was
compared with those who underwent deployment in zone
3 or 4 (2/82, 2.4%), the difference approached significance
(2 analysis; P  .06).
Two CVAs occurred in patients whose left SCA had
been completely covered. One of the CVAs was discovered
the day after endograft repair and was assessed from CT
imaging of the brain to be embolic. The second patient’s
CVA occurred secondary to hypotension during an intra-
operative cardiac arrest that occurred immediately after
emergent endograft deployment to treat an acute type B
dissection involving malperfusion of the mesenteric vessels
and lower extremities. The patient’s CVA was demon-
strated to have occurred in a left frontoparietal watershed
distribution, and MRA demonstrated a patent basilar sys-
tem supplied by the right vertebral artery. The patient who
experienced a CVA after partial coverage was assessed to be
embolic by CT imaging.
Overall, 19 (68%) of the 28 patients experienced a
complete cessation of antegrade flow through the origin of
their left SCAwithout revascularization either at the time of
endograft deployment (n  14), after a secondary proce-
dure (n  2), or due to vessel thrombosis (n  1). Left
upper extremity symptoms developed in three patients
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(5.3%) required a secondary procedure to treat rest pain.
DISCUSSION
Of the 28 patients who underwent zone 0, 1, or 2
deployment, 19 experienced complete cessation of ante-
grade flow through the left SCA. Four (21%) of these
patients experienced left upper extremity symptoms, but
only one (5%) required an intervention. As described, this
patient was treated emergently for a ruptured mycotic
aneurysm and was known to have an aortic arch origin of
the left vertebral artery. Our 21% incidence of left upper
extremity symptoms is consistent with previous observa-
tions after left SCA coverage without revascularization, in
which approximately 63% to 100% of patients remain
asymptomatic at follow-up and most do not have symp-
toms severe enough to require an intervention.5-7,12 In
earlier reports, the left SCA was routinely revascularized
before endograft coverage owing to concern about the
potential for left upper extremity ischemia and vertebro-
basilar insufficiency,13 but these more recent results suggest
prophylactic revascularization is not necessary.
When symptoms occur after left SCA coverage they may
include neurologic signs consistent with vertebrobasilar insuf-
ficiency as well as left upper extremity hypoperfusion, such as
claudication, rest pain, or ischemia. To decrease the likelihood
of these complications, patients should undergo preproce-
dural carotid and vertebral duplex ultrasound imaging, digital
subtraction angiography, CTA, or MRA to evaluate for the
patency, size, and location of the contralateral vertebral artery
as well as to rule out an aortic arch origin of the left vertebral
artery. The carotid arteries should also undergo concomitant
evaluation to rule out stenosis. Cerebral angiography orMRA
has a role in determining the presence of an intact circle of
Willis to exclude a dominant left vertebral artery system and to
ensure sufficient collateral blood flow.
Contraindications to left SCA coverage without pre-
procedural left SCA revascularization include an aberrant
left vertebral artery, a dominant left vertebral artery blood
supply to the basilar system, previous coronary artery by-
pass procedure with a patent left internal mammary artery,
and a functioning arteriovenous fistula in the left upper
extremity. For patients who develop left upper extremity
symptoms, later revascularization can be performed de-
pending upon the severity of these symptoms and should be
considered in situations of left-handed professionals,
younger patients, or when these symptoms are lifestyle
limiting; otherwise, expectant management is appropriate.
Partial left SCA coverage was well tolerated owing to
persistent antegrade flow through the ostium of the vessel
but may have placed patients at risk for the development of
type IA endoleaks, as was observed in two patients. This is
due to the difficulty of obtaining adequate proximal stent
graft apposition to the distal arch curvature in the territory
near the left SCA. Partial occlusion may also lead to vessel
thrombosis, as was observed in one patient in our series.
Because of the risks of eventual occlusion of the left SCA
and some uncertainty about how the endograft will con-form to the curvature of the arch at the time of deployment,
preoperative evaluation should be identical for patients in
whom some degree of impediment upon the ostium of the
left SCA is anticipated.
Left SCA revascularization options before and after
endograft deployment include CCA–SCA bypass or trans-
position (Fig, A and B).14 Although both of these proce-
dures are technically straightforward, they do have associ-
ated morbidity.15,16 It is unknown which procedure is
more advantageous when used concomitantly with thoracic
endograft repair, although previous studies have suggested
an advantage in terms of long-term patency with left SCA–
left CCA transposition in the setting of arterial occlusive
disease.15,17 Additional techniques described to revascular-
ize the left SCA include endovascular transluminal graft
fenestration,18 and transluminal placement of endovascular
stents at the ostia of the supra-aortic vessels to re-establish
or ensure blood flow.19,20
CVAs in this subgroup of 28 patients appeared to occur
at a higher incidence compared with our overall series of
patients, although this did not reach statistical significance
(P  .06). Catheter, wire, and sheath manipulations in the
aortic arch during stent graft deployment may be a source
of emboli. Larger studies may confirm if patients with
proximal aortic lesions are at greater risk for this complica-
tion with endograft repair. No cases of paraplegia occurred
within this subgroup, nor have there been in our overall
series of 112 patients. Given that the vertebral artery sup-
plies the superior portion of the anterior spinal artery,
coverage of the left SCA may disrupt an important collat-
eral source of spinal perfusion in patients with prior AAA
repair as well as in those who will undergo extensive tho-
racic aortic coverage.
Our study is limited by its retrospective design, diver-
sity of thoracic aortic pathology, combination of elective
and emergent repairs, small numbers, and limited follow-up.
Preoperative radiographic evaluation of elective patients
Fig. Options for left subclavian artery revascularization. A, Trans-
position of the left subclavian artery to the left common carotid
artery. B, Bypass of the left common carotid artery to the left
subclavian artery.allowed for identification of patients at risk for left upper
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basilar insufficiency or stroke based upon cerebrovascu-
lar anatomy.
CONCLUSION
Coverage of the left SCA origin usually does not lead to
left upper extremity ischemic symptoms and can be man-
aged expectantly. Although manipulation of guidewires
and deployment devices within the arch may place patients
at risk for embolic events, left SCA coverage appears to be
well tolerated in individuals with collateral perfusion to the
basilar system. Partial left SCA coverage may place the
patient at risk for the development of a type IA endoleak.
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Dr Joseph Coselli (Houston, Tex). The authors should be
congratulated on a very fine presentation. This is going to be a very
important contribution providing additional baseline data regard-
ing left subclavian artery occlusion during thoracic stent grafting
with exclusion of thoracic aortic pathology. The mortality and
stroke rates, however, were rather notable, both being at about
11%. This is generally higher than what we would like to see in a
minimally invasive procedure although, admittedly, in your series
nine of your patients, 32%, had undergone emergency repairs.
We, in our work, have an expanding group of these debranch-
ing procedures where the total arch is replaced using zone 1 and
would concur with your findings that, as of yet, although compli-problem. As of yet, neurological complications, in our experience,
have not occurred. We, however, have carried out all of our
procedures at the same operative setting, with both the debranch-
ing and the endovascular exclusion carried out under the same
anesthetic. Intentional coverage of the left subclavian artery has
been demonstrated to be reasonable and safe in this setting. But,
do you believe that there is a difference in the incidence of
endoleaks, particularly type 2, when the left subclavian artery arises
off an aneurysmal portion of the aorta versus arising as a branch
from a normal aortic segment where the technique is really em-
ployed to extend and enhance the proximal landing zone?
In your manuscript, which you kindly provided in advance,
you don’t address the other two strokes, and I think themanuscript
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tion of the embolic strokes. For example, were they occurring in
the distribution of the left vertebral artery?
The manuscript also does not address the issue of paraplegia.
The vertebral artery branch of the left subclavian artery is, of
course, an inflow source to the anterior spinal artery. Could you
comment further on paraplegia as an entity, both for this particular
subset of patients as well as your broader experience regarding
coverage of the descending thoracic aorta?
I would appreciate your thoughts on the routine use of CSF
drainage. You mention that you use it in patients who either had
concomitant or prior abdominal aortic aneurysm replacement. You
have an overall experience I think which would be valuable to
comment on the routine CSF drainage.
Would you please comment on the need for the immediate
availability of cardiopulmonary bypass when using zone one?
Emergency cases seem to pose several problems that might
make ischemic complications more likely. Understandably, they
may not undergo sufficient evaluation of cerebral circulation be-
fore the procedure and may present with associated shock and
coexisting injuries making their neurological status difficult to
assess. Similarly, their early postoperative course may make neuro-
logical assessment challenging. Finally, ongoing global hypoperfu-
sion, as you had in one of your own patients due to organ failure
and other injuries, may exacerbate ischemic complications. Given
these concerns, should the left subclavian artery be routinely
revascularized during stent graft placement where you had these
conflicting issues?
Finally, do you have a concern about the long-term durability
of an unsupported ascending aorta for a proximal landing site, not
only in patients with significant connective tissue issues, such as
Marfan syndrome or Ehler-Danlos syndrome, but also in patients
with reduced aortic wall strength and integrity of lesser severity
such as those with bicuspid aortic valves, etc? You have recom-
mended that the patients undergo preprocedural studies to iden-
tify those at risk for vertebrobasilar insufficiency, yet the informa-
tion obtained, at least in your manuscript, was not actually used to
modify the procedures carried out. Would you comment, conse-
quently, on how strongly you recommend this process?
Dr Paul J. Riesenman. Thank you, Dr Coselli. To address
some of those issues, with respect to our three strokes, as I said in
the presentation, one patient did sustain his CVA as a consequence
of his intraoperative cardiac arrest, and it was a watershed pattern
seen on subsequent CT scan. An additional patient had a similar
pattern and appeared to be possibly from a hypotensive episode.
The other patient actually did not have any radiographic signs or
evidence of stroke but he did have clinical symptoms of it. All those
patients underwent MR evaluation, which showed that the stroke
was not a consequence of a loss of blood flow to the vertebrobasilar
territory, so these were not strokes within that territory. If they
were, we would conclude they were a consequence of coverage of
the left subclavian and cessation of blood flow to the left vertebral.
With respect to our paraplegia, we have not seen—yes, the left
vertebral can contribute to flow through the anterior spinal ar-tery—but we have not had any evidence of paraplegia in our overall
group, nor have we in this subgroup whatsoever.
With respect to routine CSF drainage, we typically only use
that in patients who have undergone previous abdominal aortic
aneurysm repair but not necessarily in patients who do not have
pathology below their diaphragm.
There were several other questions. I can’t remember them all
that you proposed to me.
Dr Mark Farber. Let me add to that. Dr Riesenman is a
third-year resident in our program and he has done a terrific job,
but to answer some of the issues that Dr Coselli brings up in terms
of the routine left subclavian artery revascularization, we do eval-
uate our patients either with CTA orMRA of the circle of theWillis
and the entire system and you can do that in most emergent cases
except the patients who come in with ruptured aneurysms. The
transection patients and dissection patients, they usually get that
type of evaluation. We are looking for a few things. We want to
make sure that they do not have a left vertebral that comes off the
arch. The one patient that did have some rest pain had a left
vertebral that came off the arch, and that is what provides the
outflow to the left arm and prevents most of these patients from
becoming symptomatic.
The second thing that we are looking at is, obviously, if they
had a coronary bypass graft, do you have a bypass graft based off
the left subclavian system as inflow? We do not want to create a
coronary problem for them.
In the two other situations to come up, about 0.4% of the
patients will have a left vertebral that does not form up with the
right vertebral to give you a true basilar, complete system, and they
will suffer a posterior stroke if you cover the left subclavian or what
we call dominant left vertebral artery situations.
Lastly, Peter Linn presented some anatomic variants where the
right vertebral will actually come off distal to the left subclavian
artery and so, technically, you could cover both vertebrals up if you
cover the left subclavian and then have a vertebral that is aberrant
and comes off distally, so each of those things have to be looked at.
You have to know that those are low incidence of anomalies that
exist and that you are going to address those.
Lastly, routine use of CSF drainage. While all of us have these
anecdotal issues where we put a CSF catheter in and got resolution
of spinal cord paraplegia, there is no data that shows it has been of
benefit in any level 1 instance. There are several of us that have
gotten together and have a proposal to get together to do this as a
nationwide evaluation of CSF drainage for thoracic endograft to
see if there is a benefit, what the risks are to it, and see if we can
improve it.
Lastly, Dr Coselli mentioned the stroke risk being higher than
what we’d like. That is true of all thoracic endograft procedures. It
is higher than our paraplegia risks in most studies. Ours was 11%,
but you are working further around in the arch and I would say that
raises it from the 6% to 8% that we see for a zone 3 or zone 4
deployment and raises it somewhat. You have to be very careful
with your technique and what you are doing.
